Figure 4From: Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?Changes in total Sharp score in patients with active rheumatoid arthritis who were given one of two dosages of adalimumab or placebo. Reproduced with permission from John Wiley & Sons, Inc. [36]. © 2002 American College of RheumatologyBack to article page